# Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer

> **NCT00880854** · PHASE1 · WITHDRAWN · sponsor: **University of Wisconsin, Madison**

## Conditions studied

- Bladder Cancer

## Interventions

- **DRUG:** BCG and CP-675,206

## Key facts

- **NCT ID:** NCT00880854
- **Lead sponsor:** University of Wisconsin, Madison
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2009-06
- **Primary completion:** 2011-02
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Lack of accrual
- **Last updated:** 2019-11-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00880854

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00880854, "Study of CP-675,206 in Bacillus Calmette-Guerin (BCG)-Resistant Bladder Cancer". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00880854. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*